|
Mechanismβ1-adrenergic receptor antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date27 Dec 1989 |
100 Clinical Results associated with AdvaGen Pharma
0 Patents (Medical) associated with AdvaGen Pharma
100 Deals associated with AdvaGen Pharma
100 Translational Medicine associated with AdvaGen Pharma